Vocation Ltd is taken to the cleaners: Should you sell?

Education business Vocation Ltd (ASX:VET) has proven to be a textbook lesson in the type of IPO investors should look to avoid.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

To say Vocation Ltd (ASX: VET) investors will be unhappy today looks an understatement after the company this morning confessed to a further profit downgrade.

Having only hit the ASX boards just before last Christmas, Vocation's journey from over $3 a share in October to 15 cents today is unlikely to find its way into a Harvard MBA student's textbook on how to run a newly-listed company.

Statutory earnings for FY 2015 are now expected to be between $25-30 million. A long way off the forecast $53-57 million proclaimed as recently as October.

Things started to head downhill fast for Vocation after a Victorian government audit of some of Vocation's educational operations resulted in nearly $20 million of pulled funding. Vocation's confession over the failed audit saw the shares slump more than 70% in value as institutional investors dumped the stock en masse.

The vocational training business is blaming the latest downgrade on the fallout from the failed audit, with student enrolments down and the company's credibility coming into focus not just with investors.

Vocation already has several fee-hungry law firms on its case over its alleged failure to disclose material information and alleged misleading conduct prior to the funding loss announcement. The disappointed litigants (sore losers) are likely to be represented by Slater & Gordon Limited (ASX: SGH) and IMF Bentham Ltd (ASX: IMF), who'll be more than happy to teach Vocation a basic lesson in the realities of the Corporations Act.

This all goes to show that investing is a high risk business in which it's crucial to be confident your money is going into businesses with first-class management and big growth runways.

Motley Fool contributor Tom Richardson owns shares in Slater and Gordon. You can find him on Twitter @tommyr345

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »